p-Aminobenzoic acid derivatives as acetylcholinesterase inhibitors

José Correa-Basurto, Iván Vázquez Alcántara, L. Michel Espinoza-Fonseca, José G. Trujillo-Ferrara

Research output: Contribution to journalArticle

31 Scopus citations


Because Alzheimer's disease (AD) is a medical problem characterized by progressive loss of memory and cognition that is associated with a deficient cholinergic system, this work aims to evaluate some p-aminobenzoic acid (PABA) derivatives as acetylcholinesterase inhibitors in vitro, in continuation with our last studies. The assayed compounds are low toxic, simple-structured and low cost. © 2005 Elsevier SAS. All rights reserved.
Original languageAmerican English
Pages (from-to)732-735
Number of pages658
JournalEuropean Journal of Medicinal Chemistry
StatePublished - 1 Jul 2005


Cite this